Michele McElvain
Integrated BioTherapeutics (United States)(US)
Publications by Year
Research Areas
CAR-T cell therapy research, Sphingolipid Metabolism and Signaling, Carbohydrate Chemistry and Synthesis, Lipid Membrane Structure and Behavior, Immunotherapy and Immune Responses
Most-Cited Works
- → Potent hFPRL1 (ALXR) agonists as potential anti-inflammatory agents(2006)125 cited
- → Osteoblast Precursor Cells are Found in CD34 + Cells from Human Bone Marrow(1997)111 cited
- → Discovery of AMG 369, a Thiazolo[5,4-b]pyridine Agonist of S1P1 and S1P5(2010)54 cited
- → A carcinoembryonic antigen-specific cell therapy selectively targets tumor cells with HLA loss of heterozygosity in vitro and in vivo(2022)52 cited
- → Functional arrays of human pluripotent stem cell-derived cardiac microtissues(2020)47 cited
- → Benzofuran Derivatives as Potent, Orally Active S1P1 Receptor Agonists: A Preclinical Lead Molecule for MS(2010)37 cited
- → Long-Term Low Ascorbic Acid Intake Reduces Bone Mass in Guinea Pigs(1996)27 cited
- → Potent, Selective CARs as Potential T-Cell Therapeutics for HPV-positive Cancers(2021)24 cited
- → 4-Methoxy-N-[2-(trifluoromethyl)biphenyl-4-ylcarbamoyl]nicotinamide: A Potent and Selective Agonist of S1P1(2011)20 cited
- → Discovery of a Potent, S1P3-Sparing Benzothiazole Agonist of Sphingosine-1-Phosphate Receptor 1 (S1P1)(2010)19 cited